Large-conductance voltage and Ca 2 þ -activated potassium channels (BKCa) play a critical role in modulating contractile tone of smooth muscle, and neuronal processes. In most mammalian tissues, activation of b-adrenergic receptors and protein kinase A (PKA c ) increases BKCa channel activity, contributing to sympathetic nervous system/hormonal regulation of membrane excitability. Here we report the requirement of an association of the b2-adrenergic receptor (b2AR) with the pore forming a subunit of BKCa and an A-kinase-anchoring protein (AKAP79/150) for b2 agonist regulation. b2AR can simultaneously interact with both BKCa and L-type Ca 2 þ channels (Ca v 1.2) in vivo, which enables the assembly of a unique, highly localized signal transduction complex to mediate Ca 2 þ -and phosphorylation-dependent modulation of BKCa current. Our findings reveal a novel function for G protein-coupled receptors as a scaffold to couple two families of ion channels into a physical and functional signaling complex to modulate b-adrenergic regulation of membrane excitability.
Introduction
Large-conductance voltage and Ca 2 þ -activated potassium channels (BKCa), encoded by the gene Slo1 (Butler et al, 1993) , are regulated extensively by alternative splicing (Lagrutta et al, 1994) , phosphorylation/dephosphorylation and associated regulatory proteins such as b subunits (Brenner et al, 2000) . BKCa/Slo channels are activated by depolarization and elevated cytosolic Ca 2 þ . In neurons, BKCa channels have been localized to cell bodies and nerve terminals (Knaus et al, 1996) and can functionally colocalize with Ca 2 þ channels at presynaptic terminals (Robitaille et al, 1993) . In neurons, the channels underlie the fast after-hyperpolarization that contributes to resetting the membrane potential during an action potential (Storm, 1987) . In presynaptic terminals, the channels are believed to influence synaptic transmission by hyperpolarizing the plasma membrane, thereby limiting Ca 2 þ influx (Storm, 1987; Lancaster et al, 1991; Robitaille et al, 1993; Joiner et al, 1998) . In smooth muscle, BKCa channels hyperpolarize the membrane, thereby indirectly reducing contractility (Nelson et al, 1995) . The direct regulation of BKCa mediates, in part, the bronchorelaxant and vasorelaxant properties of b agonists (Schubert and Nelson, 2001; Pelaia et al, 2002 ).
An emerging concept in ion channel regulation is that modulation by phosphorylation is controlled by local signaling mechanisms (Marx et al, 2000 (Marx et al, , 2001 Davare et al, 2001) . BKCa channels are potently modulated by reversible protein phosphorylation Reinhart et al, 1991; Schubert et al, 1999; Schubert and Nelson, 2001; Zhou et al, 2001) . Prior studies have established that BKCa is a substrate of protein kinase A (PKA c ) (Sadoshima et al, 1988; Kume et al, 1989; Nara et al, 1998) that can activate or inhibit channel activity, depending on the splice isoform (Carl et al, 1991; Tian et al, 2001; Fury et al, 2002) . BKCa channels are also phosphorylated by protein kinase C (PKC) (Minami et al, 1993; Zhou et al, 2001 ) and protein kinase G (PKG) (Kume et al, 1992; Alioua et al, 1998) at distinct sites (Zhou et al, 2001) . To add to the complexity of regulation, cross-activation of PKG by cAMP-dependent vasodilators has been described (White et al, 2000; Barman et al, 2003) . Although several studies have suggested that kinase(s) is/are tethered to the BKCa channel Wang et al, 1999; Tian et al, 2003) , the macromolecular complex that facilitates b-adrenergic receptor (b-AR) signaling to the BKCa channel has not been clearly elucidated. We identified the requirement of an association between the b2-adrenergic receptor (b2AR), A-kinase-anchoring protein (AKAP79/150) and BKCa channel to enhance b2 agonist regulation of the channel. Moreover, as b2ARs can dimerize (Angers et al, 2000) and simultaneously interact with both BKCa and L-type Ca 2 þ channels (LTCC) (Davare et al, 2001 ), a functional macromolecular signaling complex is created that permits the rapid response to b2 agonist.
by the addition of a PKA inhibitor, PKI 5-24 ( Figure 1A ). BKCa immunoprecipitated from brain is also phosphorylated in the presence of cAMP, in the absence of exogenous PKA c . The phosphorylation induced by cAMP is inhibited by PKI, suggesting that BKCa is closely associated in vivo with an endogenous PKA c ( Figure 1B) Esguerra et al, 1994) . This endogenous kinase bound to the channel is inactive, as the BKCa channel immunoprecipitated by brain was not phosphorylated with the exclusion of cAMP ( Figure 1A ). PKA c can be completely dissociated from the BKCa complex by cAMP ( Figure 1C ), indicating that the catalytic subunit engages the complex through a regulatory subunit (holoenzyme), rather than via a distinct site on the catalytic subunit, as is the case for PKA c and Drosophila BKCa (dSlo) interaction (Zhou et al, 2002) . When cAMP was not preincubated with the immunoprecipitates prior to in vitro phosphorylation, a strong phosphorylation signal is detected ( Figure 1C ). These data suggest that BKCa is part of a macromolecular complex that underlies the regulation of the channel by b2AR signaling/processes that elevate intracellular cAMP.
b2AR associates with neuronal and smooth muscle BKCa channel Given the importance of adrenergic input for regulating membrane excitability and BKCa function, we sought to determine whether BKCa associates with b-ARs. Although both b1AR and b2AR are expressed in the brain (Figure 2A ), b2AR, but not b1AR (data not shown), is associated with BKCa ( Figure 2B ). BKCa colocalized/distributed with b2AR in the soma of mouse brain cortical neurons ( Figure 2C ) and in cerebellar Purkinje cells, and in basket and stellate cells in the molecular layer of the cerebellum (data not shown).
BKCa channels play a significant role in the regulation of vascular (Brenner et al, 2000) , pulmonary (Pelaia et al, 2002) and uterine (Wallner et al, 1995) smooth muscle contraction, and modulation of BKCa by b-ARs represents an important therapeutic target. Immunoprecipitation of b2AR from extracts of tissues enriched in smooth muscle such as bladder, aorta and lung ( Figure 2D ) demonstrated a specific association with BKCa channels. Negative controls included b1AR and b2AR antibody alone (without lysate), preimmune serum (with lysate) and peptide-blocked b2AR antibody (with lysate). As the regulation of arterial tone is dependent on vascular smooth muscle cell (VSMC) contractility, we sought to determine whether the complex was present in isolated VSMCs. Consistent with this role, the association of b2AR and BKCa was present in VSMC as demonstrated by co-immunoprecipitation ( Figure 2D ) and confocal immunofluorescence microscopy ( Figure 2E ). The interaction was specific, as the b1AR, although expressed in vascular smooth muscle and lung as determined by immunoblot ( Figure 2A and data not shown), was not associated with the channel ( Figure 2D ).
Formation of BKCa-b2AR-AKAP79/150 complex
To examine the binding determinants for BKCa on b2AR, glutathione-S-transferase (GST) fusion proteins of the b2AR intracellular loops were prepared and assayed for their ability to interact with BKCa in brain extracts. Mapping of the interaction sites revealed that only the third intracellular (i3) loop associated with the channel (Figure 3 ). GST fusion proteins containing the other intracellular domains (i1, i2 and C-terminus) failed to co-precipitate the channel.
Prior studies have demonstrated that AKAP79/150 (Fraser et al, 2000) and gravin bind to b2AR (Shih et al, 1999; Tao et al, 2003) . b2AR can co-immunoprecipitate AKAP150, the rodent homolog of AKAP79 from rat brain lysates ( Figure 4A ). We hypothesized that the BKCa-b2AR complex might recruit an AKAP due to the constitutive binding of an AKAP to b2AR (Shih et al, 1999; Fraser et al, 2000) . In rat brain lysates, AKAP150 could be co-immunoprecipitated with BKCa ( Figure 4B ), indicating that a BKCa-b2AR-AKAP150 complex exists in native tissue.
The b2AR-BKCa interaction can be reconstituted in HEK293 cells after expression of both myc-b2AR and BKCa ( Figure 5A ). b2AR constitutively recruits AKAP79 (Fraser et al, 2000) (Figure 5B ), which enables the targeting of AKAP79 to the channel ( Figure 5C ). Without expression of b2AR, AKAP79 cannot associate with BKCa ( Figure 5C ), demonstrating the requirement for AKAP79 binding to b2AR in order to assemble the AKAP79-BKCa complex. Overexpression of AKAP79 is not required for b2AR-BKCa interaction ( Figure 5A ). Likewise, overexpression of BKCa is not required for b2AR-AKAP79 association ( Figure 5B ). The binding of both AKAP79 and BKCa to b2AR ( Figure 5C ) is not mutually exclusive, consistent with the findings that BKCa associate with b2AR via the third intracellular loop (i3; Figure 3 ) and AKAP79 associates with b2AR via the third intracellular loop and the C-terminus independently (Fraser et al, 2000) . A mutant AKAP79 (FLAG-AKAP79 ) that can bind RII and PKA, but cannot associate with b2AR (Fraser et al, 2000) , was not recruited into the BKCa complex ( Figure 5D ). The coupling of b2AR and BKCa was constitutive, as it was not modulated by exposure to isoproterenol ( Figure 5E ). Collectively, these findings suggest that a functional consequence of b2AR targeting to BKCa may be the facilitation of cAMP-dependent phosphorylation of BKCa by an anchored pool of PKA holoenzyme.
Macromolecular signaling complex enhances b2 agonist activation of BKCa
To explore the functional implications of b2AR-BKCa, we coexpressed BKCa, b2AR and AKAP79 in Xenopus oocytes. We recorded channel activity using cell-attached patch clamp and applied a specific b2 agonist, salbutamol (20 mM), either in the recording pipette by back-filling or in the bath solution (20-40 mM) (Chen-Izu et al, 2000) . The inclusion of a b2 agonist in the patch pipette increased channel activity over B10 min ( Figure 6A ), consistent with the diffusion of the agonist within the patch pipette and activation of BKCa (Po0.0005 compared to no salbutamol by Wilcoxon's rank sum test). In contrast, channel activity did not increase with bath application of salbutamol, indicating that BKCa is preferentially regulated by b2AR within the channel macromolecular complex, as opposed to those located remotely in the cell ( Figure 6B ). In a total of 23 patches recorded with salbutamol in the patch pipette, channel activity increased in 21 patches (91%) ( Figure 6C ), whereas channel activity increased in three of 10 (30%) patches recorded with bath application of salbutamol (Po0.001 compared to salbutamol in patch pipette by Wilcoxon's rank sum test) ( Figure 6C ). Immunoprecipitation specificity was demonstrated using b1AR and b2AR antibody without lysate (in VSMC samples), preimmune serum or b2AR peptide-blocked antibody ( þ pep) in lung and VSMC samples. b2AR specifically co-immunoprecipitates with BKCa channels. 'cont' is 5% input. (E) Representative confocal images of immunostaining for b2AR (green) and BKCa (red) in isolated human VSMCs. BKCa and b2AR are colocalized/distributed (merged images). Scale bar, 10 mm. Figure 3 Specific interaction of the b2AR third intracellular loop and BKCa channel. Representation (left) of b2AR; GST fusion proteins were prepared for the three intracellular loops (i1-i3) and the C-terminus (Cterm). Rat brain extracts were incubated with the GST fusion proteins bound to glutathione sepharose. For GST-i3, pull-downs were performed with increasing amounts of GST fusion proteins to demonstrate specificity of interaction. After extensive washing, samples were size-fractionated on SDS-PAGE and transferred to nitrocellulose. Immunoblots (right; upper GST antibody, lower BKCa antibody) demonstrate that only GST-i3 specifically co-precipitated BKCa channel. The likelihood of channel activation with salbutamol in the patch pipette was substantially enhanced by expression of the three macromolecular components, as compared to expression of BKCa alone, BKCa þ AKAP79 or BKCa þ b2AR ( Figure 6C ). BKCa activity could be increased only when the channel was coexpressed with b2AR, indicating the lack of endogenous b2AR in Xenopus oocytes. Thus, the colocalization of b2AR and BKCa channel, along with AKAP79 is required for full functional regulation. In addition, the increase of BKCa current in the cell-attached patch was not due to an increase in Ca 2 þ entry into the oocyte, as the free Ca 2 þ concentration in pipette solution and bath solution was very low, either 0.5 nM (5 mM EGTA) or B10 mM (without EGTA). The magnitude of current increase (%) varied extensively ( Figure 6D ; box plot), an effect that may be due to the variable expression efficiency and/or the time between back-filling the agonist and the formation of the gigaseal. However, the magnitude of current increase was significantly smaller with bath application than that caused by agonist in the patch pipette ( Figure 6D ; box plot). Although channel activity increased in response to pipette salbutamol in two of five patches (40%) when AKAP79 was not coexpressed, the magnitude of current increase was less than when three components were expressed ( Figure 6C and D) . These findings suggest that expression of AKAP79 increases the likelihood of salbutamol-mediated modulation ( Figure 6C and D). Xenopus oocytes may contain an endogenous AKAP or, alternatively, signaling pathways other than the AKAP-mediated pathway may contribute to the modulation of BKCa. Overall, only expression of all three components of the complex reconstituted full-b2 agonist modulation of the channel ( Figure 6D ; circles).
LTCC associate with BKCa channel through b2AR-dependent scaffold b2ARs in native tissue and expressed in HEK293 cells form SDS-resistant dimers ( Figure 7A ) (Angers et al, 2000; Salahpour et al, 2003) , which associate with BKCa ( Figure 7B ). Although, G protein-coupled receptors (GPCRs) are thought to function independently as monomers to signal to effector molecules, recent studies have suggested that oligomerization (dimerization) of GPCRs in vivo is a constitutive process, dependent on disulfide bonds and hydrophobic packing (Salahpour et al, 2003) , that provides an additional level of functional complexity for their responses (Barki-Harrington et al, 2003) . Our findings of b2AR dimerization are consistent with prior reports, although the extent of dimerization seen on SDS-PAGE may not correlate with the extent of dimerization in situ.
As the b2AR can dimerize and associate with BKCa ( Figure 7B ) and LTCC (Davare et al, 2001) , we hypothesized that b2AR might act as a scaffold that not only facilitates cAMP-mediated regulation of the channels but also recruits both ion channels into a macromolecular complex. Despite the observations that Ca 2 þ influx through voltage-dependent Ca 2 þ channels (VDCCs) can activate BKCa (Roberts et al, 1990; Gola and Crest, 1993; Nelson et al, 1995; Marrion and Tavalin, 1998; Herrera and Nelson, 2002; Sun et al, 2003) , a physical association between the ion channels has not been demonstrated. Immunoprecipitation of LTCC from brain and bladder extract revealed that the channel was part of the BKCa complex ( Figure 8A ). The association was specific, as the co-immunoprecipitation could be blocked by preabsorption of the antibody with a1c peptide ( Figure 8A ).
We next examined whether b2AR was required for the assembly of the BKCa-LTCC complex. Coexpression of BKCa, b2AR, and LTCC a1c/b 2a subunits reconstituted the association ( Figure 8B ). The co-immunoprecipitation was blocked by a1c peptide ( Figure 8B ). The interaction was dependent on b2AR expression because the association was not present in HEK293 cells coexpressing only BKCa and a1c/b 2a ( Figure 8B ). These findings indicate that the assembly of the BKCa-LTCC (a1c þ b 2a ) complex was dependent on b2AR expression. To examine the role of the LTCC b subunit in the assembly of the complex, we coexpressed b2AR, BKCa and a1c in HEK293 cells. The assembly of the BKCa-LTCC complex was dependent on b2AR expression, but not b 2a subunit expression ( Figure 8C ). Exposure of HEK293 Figure 6 Localized upregulation of BKCa channels via b2AR signaling. (A, B) Representative current traces of BKCa channels coexpressed with b2AR and AKAP79 in a Xenopus oocyte. Channel activity was recorded using cell-attached patch clamp during 20 ms, þ 150 mV test pulses from À50 mV, and then returned to À50 mV. Salbutamol (20 mM) was applied in the patch pipette by back-filling (A) or in the bath (B). A total of 100 sweeps were applied at various times as indicated. Sweeps 10, 40 and 80 at each time are shown. 'c' represents closed state of the channel. Average currents of all 100 sweeps are shown at the bottom at the indicated times (min) after the GO seal formation (A) or bath application of salbutamol (B). (C) Total number of patches that have been recorded versus the number of patches in which an increased open probability of BKCa (P o increase 410%) was observed. Inclusion of salbutamol in the patch pipette significantly increased the number of patches which demonstrated P o increase as compared to bath application. Increased BKCa channel P o was dependent on coexpression of b2AR-AKAP79. (D) Graph of data set summarizing average currents of all 100 sweeps 15 min after salbutamol application. In the box plot, patches without P o increase are excluded. In each box, the mid-line shows the median value, the top and bottom lines show the 75th and 25th percentiles, and the whiskers show the 90th and 10th percentiles. The circles are means of data, including patches without P o increase, and error bars are standard error of means. For experiments on coexpression of BKCa, b2AR and AKAP, the P-value of Wilcoxon's rank sum test o0.0005 between pipette application of salbutamol and no salbutamol (left two circles), and o0.001 between pipette application and bath application of salbutamol (left and right circles). cells expressing b2AR, LTCC and BKCa channel to a b agonist (isoproterenol) did not affect the association of BKCa and LTCC ( Figure 8D ). These findings indicate a novel function for b2AR as a scaffold to permit the physical association of two families of ion channels, which have been previously reported to couple functionally (Figure 9 ).
Discussion
The present study offers a molecular identification of a mechanism through which BKCa channel activity is specifically regulated by b2AR signaling in brain and smooth muscle. The ability of b2AR to form a complex with BKCa, and concomitantly bind phosphorylation-modulatory components (AKAP79/150) enables specific and local regulation of BKCa channels and defines a signal transduction pathway governing cellular excitability in diverse tissues. The findings also reveal a physiologically important and unanticipated role of b2AR: that of serving as a nonphosphorylation-dependent scaffold to enable regulation of BKCa channels by LTCC.
A common theme in signal transduction is the close association of signaling molecules with effectors to enable specific and local regulation (Pawson and Scott, 1997) . Specificity of PKA anchoring is achieved by targeting motifs that direct AKAPs to specific cellular sites (Pawson and Scott, 1997) . AKAP79/150 has been demonstrated to interact with PKA, PKC and calcineurin (Klauck et al, 1996) . The associated PKA and PKC are maintained in an inactive state when bound to AKAP79, but can be activated by cAMP or diacylglycerol (Faux et al, 1999) . AKAP79/150 associates with b2AR in brain, regulating the phosphorylation state of the receptor (Fraser et al, 2000) . Our findings suggest that association of AKAP79/150 with b2AR enables the facilitation of phosphorylation of BKCa and LTCC in response to b agonists. As the BKCa channel is also regulated by PKC, it remains to be determined whether the assembly of the b2AR-BKCa-AKAP79/150 complex facilitates regulation by PKC. A recent report has suggested that PKA is targeted to the BKCa channel through leucine zipper-mediated interactions (Tian et al, 2003) , similar to leucine zipper-mediated interactions described for ryanodine receptors (Marx et al, 2000 (Marx et al, , 2001 , KCNQ1 and Ca v 1.1/Ca v 1.2 (Hulme et al, 2002 (Hulme et al, , 2003 . Our findings do not preclude BKCa channel association with PKA in native tissues through additional mechanisms. Thus, the BKCa channel is actively regulated by a macromolecular complex that enables specific regulation by kinases and phosphatases (Carl et al, 1991; Reinhart and Levitan, 1995; Sansom et al, 1997; Widmer et al, 2003) .
Although the role of kinases and phosphatases has been relatively well studied in numerous systems, there has been limited information regarding the effects in specific neuronal cells. PKA phosphorylation activates BKCa channels in many, but not all, cell types. In smooth muscle, most but not all studies have shown that PKA phosphorylation leads to activation of the channel (Schubert and Nelson, 2001 ). However, cAMP-induced activation of PKG (cross-activation) has been described, potentially leading to channel activation through PKG phosphorylation (White et al, 2000) . Our findings of a b2AR-BKCa complex does not preclude the cross-activation hypothesis, but rather serves to highlight a mechanism through which generation of cAMP through activation of the closely associated b2AR can lead to modulation of BKCa channels. Moreover, adenylyl cyclase has been reported to co-purify with Ga s and Gb subunits (Bar-Sinai et al, 1992) and colocalizes with LTCC in rabbit cardiac myocytes (Gao et al, 1997) and with the b2AR-LTCC complex in brain (Davare et al, 2001) . Thus, the formation of a b2AR-BKCa complex can lead to a highly organized scaffold that facilitates cAMP-dependent phosphorylation.
Most binding sites for b2AR interacting proteins are within the third intracellular loop and C-terminus. The C-terminus has been reported to interact with the LTCC (Davare et al, 2001) and Na þ /H þ exchanger regulatory factor (NHERF) (Hall et al, 1998) . AKAP79/150, which modulates PKA phosphorylation of b2AR and GPCR kinase 2 (GRK2) (Cong et al, 2001) , interacts with the b2AR third intracellular loop and C-terminus (Fraser et al, 2000) . BKCa channel interacts directly with only the b2AR third intracellular loop. Unlike heterotrimeric G proteins, arrestins (Rockman et al, 2002) and NHERF (Hall et al, 1998) , which bind to b2AR in an agonist-dependent manner, AKAP79/150 (Fraser et al, 2000) , and BKCa bind to b2AR constitutively. Moreover, the BKCa-LTCC channel complex is not dependent on the b2AR activation state. The amino-acid sequence of the b1AR third intracellular loop markedly differs from that of b2AR, consistent with our findings that b2AR, but not b1AR, binds to BKCa in vivo (Green and Liggett, 1994) . The association of b2AR and BKCa is required to permit b2 agonist activation. The inclusion of the b2 agonist in the patch pipette significantly increased the likelihood of channel activation as compared to bath application. This finding demonstrates that BKCa channels are preferentially activated by local b2 agonist signaling. Prior studies have demonstrated that the BKCa channel can be activated by extracellular exposure to isoproterenol (a b1 and b2 agonist) (Sadoshima et al, 1988; Kume et al, 1989) . This finding highlights the distinction between b1AR and b2AR stimulation in that b1 agonists can activate the channel both locally and remotely, whereas b2 agonists modulate BKCa channels only locally. Prior studies indicated that b2AR signaling leading to activation of LTCC is also highly localized in cardiac muscle and neurons, potentially due to the coupling of both Ga s and G i to b2AR (Chen-Izu et al, 2000; Davare et al, 2001; Xiao, 2001) . The likelihood of spontaneous activation of BKCa channels coexpressed with b2AR and AKAP79 (without b2 agonist in patch pipette) was similar to activation after bath application of the b2 agonist. This finding may be explained by the occurrence of spontaneous activation of b2AR (Zhou et al, 2000) . The magnitude of BKCa current increase was greatest upon coexpression of b2AR and AKAP79 and activation of b2AR locally. Only coexpression of all three components of the macromolecular complex reconstituted full b2 agonist modulation.
The source of Ca 2 þ for activation of BKCa has been the subject of intense investigation. Several studies have suggested a functional linkage between the BKCa channel and voltage-dependent Ca 2 þ channel and/or ryanodine receptor, although the specific subtype of voltage-dependent Ca 2 þ channel has been variable (Roberts et al, 1990; Gola and Crest, 1993; Nelson et al, 1995; Marrion and Tavalin, 1998; Pineda et al, 1998; Herrera and Nelson, 2002; Sun et al, 2003) . In hippocampal neurons, LTCC have been suggested to couple functionally to small-conductance calcium-activated channels (SK), whereas Ca 2 þ influx through N-type Ca 2 þ channels activates BKCa channels (Marrion and Tavalin, 1998) . In contrast, conflicting data have been shown in neocortical neurons, with reports demonstrating Ca 2 þ influx via both L-and N-type Ca 2 þ channels activates BKCa channels in mouse neocortical pyramidal neurons (Sun et al, 2003) , but only N-, P-and Q-type currents activate BKCa channels in rat neocortical pyramidal neurons (Pineda et al, 1998) . In vascular smooth muscle, the activation of LTCC can increase [Ca 2 þ ] i in the environment of a neighboring BKCa channel leading to its activation (Guia et al, 1999) . Activation of BKCa channels was independent of ryanodine receptor activity and could be inhibited by nifedipine. These data support the premise that BKCa and LTCC are colocalized on the smooth muscle cell membrane. Consistent with these findings, urinary bladder smooth muscle steady-state BKCa channel activity is highly dependent on Ca 2 þ entry through VDCCs, whereas transient BKCa currents require local communication from ryanodine receptors (Ca 2 þ sparks) to BKCa channels (Herrera and Nelson, 2002) . Therefore, we have identified a novel mechanism that can mediate the functional coupling of Ca 2 þ influx through LTCC and activation of BKCa channels; b2AR can act as a scaffold to bridge the two families of ion channels into a macromolecular complex. Taken together, b2AR localization with the BKCa channel can serve two important purposes: (1) targeting of phosphorylation modulatory proteins to the channel and (2) recruitment of voltage-gated Ca 2 þ channels to the complex, Figure 9 Molecular model of macromolecular complex depicting the physical and functional regulation of the BKCa channel by b2AR/AKAP79 and a1c. Activation of b2AR by b2 agonist leads to phosphorylation of both BKCa and LTCC, resulting in increased BKCa channel activity.
contributing a source of Ca 2 þ for BKCa channel activation. The formation of the macromolecular complex is independent of b2AR activation status, leading to the constitutive formation of a signaling complex that is present in both brain and smooth muscle. Our findings describe one mechanism to bring about the colocalization of voltage-dependent Ca 2 þ channels and BKCa channels and it is conceivable that other mechanisms exist in various tissues to colocalize the two ion channels. However, in HEK293 cells, association of the two ion channels was dependent on expression of b2AR. These findings highlight a novel mechanism to assemble an ion channel macromolecular signaling complex and suggest that homo-and heterodimerization of GPCRs may provide unique scaffolds to permit the assembly of unique macromolecular complexes that regulate ion channel function.
Materials and methods
Immunoprecipitations and kinase assays Rat brain, bladder, aorta and human lung lysates were homogenized in modified RIPA buffer containing 1% Triton X-100 (v/v), (in mM) 20 EDTA, 10 EGTA, 10 Tris-HCl (pH 7.4) þ Complete minitablet (Roche), calpain I inhibitor (7 mg/ml), calpain II inhibitor (17 mg/ml) and PMSF (200 mM). Human VSMCs (Cambrex) were grown in SmGM-2 media (Cambrex) and harvested/lysed in (mM) 50 Tris-HCl (pH 7.4), 50 NaCl, Triton X-100 (1%), Complete minitablet (1 per 7 ml) and PMSF (200 mM). Insoluble material was removed by centrifugation (14K rpm Â 10 min Â 2) and supernatants were collected. Immunoprecipitations were performed in 500 ml of (mM) 50 Tris-HCl (pH 7.4), 50 NaCl, Triton X-100 (0.25%), Complete (1 per 7 ml) and PMSF (200 mM) using 2 mg b2AR (Santa Cruz, SC-569), BKCa (BD Transduction Laboratories 611248; Alomone Laboratories APC-021), c-myc (SC-40), L-type Ca 2 þ channel (Alomone, ACC-003) or AKAP150 (SC-6445) antibodies overnight. Immune complexes were collected using protein A (Amersham) or G sepharose (Sigma) for 1 h, followed by extensive washing. All immunoprecipitations included negative controls (peptide-blocked, preimmune, antibody alone). In addition to the antibodies listed above, additional antibodies utilized for immunoblotting include GST-HRP (SC-138) and AKAP79 (BD Transduction Lab-610314). Blots were developed with the use of ECL (Amersham) or Supersignal detection (Pierce). Input represents 5% of immunoprecipitation except 0.3% for co-immunoprecipitations of LTCCBKCa and AKAP150-BKCa. In all cases, data shown are representative of three or more similar experiments.
For kinase reactions, BKCa was immunoprecipitated from rat brain lysates (1 mg) captured on protein A-sepharose, washed, followed by resuspension in kinase reaction buffer (in mM, 8 MgCl, 10 EGTA, 50 Tris, 50 PIPES; pH 6.8). Phosphorylation was initiated upon the addition cAMP (5 mM, Sigma), PKA c (5 U, Sigma), MgATP (33 mM) and (5 mCi) [ 32 P]gATP (Marx et al, 2001) . Reactions were terminated with 6 Â loading buffer, size-fractionated on SDS-8% PAGE and exposed to film. Negative controls included preimmune serum, absence of cAMP or PKA c , and PKI.
GST fusion proteins/co-precipitation assays GST constructs were prepared in pGEX4T-1 representing the b2AR i1 (residues 59-74), i2 (residues 127-153), i3 (217-277) and Cterminus (326-413) (Davare et al, 2001 ). Co-precipitation assays from total rat brain extract (2 mg) were performed as previously described (Marx et al, 2001 ).
Constructs
Rat BKCa was cloned via RT-PCR from brain mRNA (Clontech), sequenced and ligated into pcDNA-HisMax (Invitrogen). AKAP79 was cloned via RT-PCR from human brain mRNA (Clontech), sequenced and ligated into pCMV Tag2 (FLAG, Stratagene). Human b2AR was cloned in pCMV Tag3 (Myc, Stratagene). Constructs were transfected into HEK293 cells using Lipofectamine 2000 (Invitrogen). Transfected HEK293 cells were harvested after 24-48 h, lysed in modified RIPA buffer containing 1% Triton X-100. Transfected HEK293 cells were stimulated with isoproterenol (10 mM) (Fraser et al, 2000) for 15 min.
Immunocytochemistry
Human VSMCs were fixed with 4% paraformaldehyde (PFA) for 30 min at room temperature (RT), followed by permeabilization with Triton X-100 (0.2%) for 7 min. We used a Cy3 kit tyramide amplification kit (NEL704A; Perkin-Elmer) for detection of BKCa (BD Bioscience; 1:50). b2ARs were detected by conventional fluorescent staining using b2AR Ab (1:100) and goat anti-rabbit Alexa Fluor 488 (Jackson Immunoresearch, 1:300). Fluorescent images were obtained using a Bio-Rad MRC-600 scanning attachment mounted on a Zeiss Axiovert fluorescence microscope. To confirm specific binding of both BKCa and b2AR antibodies, the binding was blocked with corresponding excess antigen or absence of primary antibody (data not shown).
Adult mice (Swiss Webster) were perfused with 4% PFA in 100 mM phosphate buffer (PBS), pH 7.4. The brains were postfixed in cold 4% PFA overnight, cryoprotected with 100 mM PBS containing 30% sucrose for 24 h at 41C and frozen in OCT (Tissue-Trek). Brain sections (20 mm) were prepared on a cryostat microtome and collected on Superfrost slides (Fisher). b2AR was detected using b2AR (1:25 000) and a Cy3 kit tyramide amplification kit; BKCa was detected by conventional fluorescent staining with anti-BKCa (Affinity Bioreagents, 1:1000) and donkey antirabbit Alexa Fluor 488 (1:500). Images were acquired using a CarlZeiss confocal microscope. To confirm specific binding of antibodies, the binding was blocked with corresponding excess antigen or absence of primary antibody (data not shown).
Electrophysiology
The mbr5 clone of mslo1 (Butler et al, 1993) , human b2AR and AKAP79 were expressed in Xenopus oocytes. Channel activities were recorded from cell-attached patches formed with borosilicate pipettes of 1-3 MO resistance. Data were acquired using an Axopatch 200-B patch clamp amplifier (Axon Instruments) and Pulse acquisition software (HEKA Electronik). Records were digitized at 20-ms intervals and low-pass filtered at 10 kHz with the Axopatch's 4 pole Bessel filter. The pipette and bath solution contained (mM): 140 K-methanesulfonic acid, 20 Hepes, 2 KCl, 2 MgCl 2 , pH 7.2, either with or without 5 mM EGTA. Salbutamol (Sigma) was either applied in the patch pipette by back-filling or in the bath with final concentrations of 20-40 mM. All recordings were obtained at RT (22-241C).
